New Drug Telavancin Tops Vancomycin in Patients with MRSA Skin Infections: Presented at ICAAC
A new drug in a similar class as vancomycin — a last resort antibiotic — appears to clear up dangerous methicillin-resistant Staphylococcus aureus (MRSA) skin infections more effectively than standard treatment.
“Usually that standard of care is vancomycin,” said Martin Stryjewski, MD, Attending Physician, Internal Medicine and Infectious Diseases, Cemic Hospital, Buenos Aires, Argentina.
.gif)
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
Leave a Comment